Atlas Trials

Relapsed or Refractory Acute Lymphoblastic Leukemia

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed or Refractory Acute Lymphoblastic Leukemia

RecordFirmDate
Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia (NCT07696481)Zhujiang Hospital2026-08-01
Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration) (NCT06367114)Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd2024-04-01
Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT04825496)Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd2021-04-09
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT04684147)Juventas Cell Therapy Ltd.2020-12-24
A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT04230473)Juventas Cell Therapy Ltd.2020-03-13
A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL (NCT03018093)Shanghai AbelZeta Ltd.2017-01-01
Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia (NCT01887587)Ehab L Atallah2013-06-01

Track Relapsed or Refractory Acute Lymphoblastic Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.